FDA Counterfeit Task Force Continues Work On Wholesaler “Best Practices”
Executive Summary
FDA's Counterfeit Drug Task Force is continuing to gather information from the drug wholesaler industry on "best practices" for reducing the risk of counterfeits in the pharmaceutical supply chain
You may also be interested in...
FDA-Approved Drug Wholesaler Inspection Program Recommended By HDMA
An FDA-approved national inspection program for drug wholesalers would ensure facilities are adequately inspected before being granted a license, the Healthcare Distribution Management Association said in Nov. 25 comments to the agency
FDA Anti-Counterfeiting Focus Should Be Wholesaler Licensing, PDA Says
FDA and states should tighten drug wholesaler licensing requirements in a way that does not "unduly restrict the interstate business of wholesaling" by licensed companies, the Pharmaceutical Distributors Association says
FDA Anti-Counterfeiting Focus Should Be Wholesaler Licensing, PDA Says
FDA and states should tighten drug wholesaler licensing requirements in a way that does not "unduly restrict the interstate business of wholesaling" by licensed companies, the Pharmaceutical Distributors Association says